Literature DB >> 28885918

Travelers' Diarrhea: An Update on the Incidence, Etiology, and Risk in Military Deployments and Similar Travel Populations.

Chad K Porter1, Scott Olson1, Alexis Hall1, Mark S Riddle1.   

Abstract

Travelers' diarrhea (TD) has historically been a common illness among visitors to developing nations. Although recent studies indicate decreasing incidence of TD among short-term travelers, a systematic review of illness among long-term travelers, including deployed military personnel, has not been conducted in more than 10 years. We conducted a literature search of studies published between 2005 and 2015 that evaluated TD in populations of deployed military personnel or similar long-term travelers (travel ≥1 month) to developing nations. Our literature search identified 28 studies for inclusion. We found that the incidence of TD remained high (10% clinical incidence, 30% self-reported incidence), with variability depending on region of travel and similar rates in both military and civilian long-term travelers. Bacteria (Escherichia coli, Campylobacter, Shigella, and Salmonella species) were the most commonly identified enteropathogens. Fifty percent of affected individuals experienced lost ability to work and 5% required hospitalization. This systematic review demonstrates that among deployed military personnel and long-term travelers, TD remains a prevalent disease that can significantly impact individual readiness for duty. These data demonstrate that to maintain operational readiness among deployed personnel, a focus on vigilance for disease and early treatment of cases is vital. Reprint &
Copyright © 2017 Association of Military Surgeons of the U.S.

Entities:  

Mesh:

Year:  2017        PMID: 28885918     DOI: 10.7205/MILMED-D-17-00064

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  28 in total

1.  Intradermal or Sublingual Delivery and Heat-Labile Enterotoxin Proteins Shape Immunologic Responses to a CFA/I Fimbria-Derived Subunit Antigen Vaccine against Enterotoxigenic Escherichia coli.

Authors:  Milton Maciel; David Bauer; Robin L Baudier; Jacob Bitoun; John D Clements; Steven T Poole; Mark A Smith; Robert W Kaminski; Stephen J Savarino; Elizabeth B Norton
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

2.  Deployment Infectious Disease Threats: IDCRP Initiatives and Vision Forward.

Authors:  Tahaniyat Lalani; Jamie Fraser; Mark S Riddle; Ramiro L Gutierrez; Patrick W Hickey; David R Tribble
Journal:  Mil Med       Date:  2019-11-01       Impact factor: 1.437

3.  Establishment and Validation of Pathogenic CS17+ and CS19+ Enterotoxigenic Escherichia coli Challenge Models in the New World Primate Aotus nancymaae.

Authors:  Eric R Hall; Aisling O'Dowd; Julianne E Rollenhagen; Nereyda Espinoza; Gladys Nunez; Stephen J Savarino
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

Review 4.  A tale of two bacterial enteropathogens and one multivalent vaccine.

Authors:  Eileen M Barry; Myron M Levine
Journal:  Cell Microbiol       Date:  2019-07-10       Impact factor: 3.715

Review 5.  Serum IgG antibodies to Shigella lipopolysaccharide antigens - a correlate of protection against shigellosis.

Authors:  Dani Cohen; Shiri Meron-Sudai; Anya Bialik; Valeria Asato; Sophy Goren; Ortal Ariel-Cohen; Arava Reizis; Amit Hochberg; Shai Ashkenazi
Journal:  Hum Vaccin Immunother       Date:  2019-05-09       Impact factor: 3.452

6.  A disease severity scale for the evaluation of vaccine and other preventive or therapeutic interventions for travellers' diarrhoea.

Authors:  Nicole Maier; Mark S Riddle; Ramiro Gutiérrez; Jamie A Fraser; Patrick Connor; David R Tribble; Chad K Porter
Journal:  J Travel Med       Date:  2022-01-17       Impact factor: 39.194

7.  The influence of perceived stress on the human microbiome.

Authors:  Austin T Almand; Allison P Anderson; Brianna D Hitt; John C Sitko; Rebekah M Joy; Benjamin D Easter; Erin A Almand
Journal:  BMC Res Notes       Date:  2022-06-03

8.  Helminth infections in the US military: from strongyloidiasis to schistosomiasis.

Authors:  Alyssa R Lindrose; Indrani Mitra; Jamie Fraser; Edward Mitre; Patrick W Hickey
Journal:  J Travel Med       Date:  2021-08-27       Impact factor: 8.490

9.  Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score.

Authors:  Chad K Porter; Amanda Lynen; Mark S Riddle; Kawsar Talaat; David Sack; Ramiro L Gutiérrez; Robin McKenzie; Barbara DeNearing; Brittany Feijoo; Robert W Kaminski; David N Taylor; Beth D Kirkpatrick; A Louis Bourgeois
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

10.  Structure of the master regulator Rns reveals an inhibitor of enterotoxigenic Escherichia coli virulence regulons.

Authors:  Charles R Midgett; Kacey Marie Talbot; Jessica L Day; George P Munson; F Jon Kull
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.